Search Results for: ACT 1 test
Press Release
OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test
05
Mar
Mar
COVID-19 test will aid healthcare professionals and public health authorities to identify patients infected with COVID-19 ELMWOOD PARK, N.J., March 05, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will offer a test for the novel coronavirus (2019-nCoV), a contagious virus that causes respiratory infection and has shown evidence of human-to-human […]
14
Feb
Feb
While February is the month of love, it also serves as Condom Awareness Month, and there’s no better time to remind you to protect yourself and your partner from Sexually Transmitted Infections (STIs) by using condoms. Using condoms every time you have sex not only protects you from STIs and unwanted pregnancies, it’s also a way to […]
13
Jan
Jan
Have you heard the news that the final Local Coverage Determination (LCD) from the Medicare MAC for the 4Kscore® Test, Novitas, is now effective. The LCD includes defined coverage criteria from Medicare, including required documentation of Shared Decision Making prior to ordering the 4Kscore Test. Full text of the final LCD can be found here. […]
Press Release
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
19
Dec
Dec
ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]
15
Nov
Nov
Medicare coverage for patients meeting certain criteria to begin as of December 30, 2019 MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore® test with defined coverage criteria, effective December 30, 2019. Full text of the […]
Proposed LCD will allow Medicare coverage within criteria for the 4Kscore® Test MIAMI, June 28, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a new proposed local coverage determination (LCD) for the 4Kscore® test, with defined coverage criteria. Under the LCD, Medicare will reimburse the test for patients who […]
17
May
May
BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).
Press Release
BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions
02
May
May
ELMWOOD PARK, N.J., May 2, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment programs at the 2019 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting in Nashville, Tennessee from May 3-6. The […]
